ribociclib
novartis
['bcsm', 'natalee', ' ribo']
natalee trial presented at #asco23 the addition of ribo for 3y to et improved 3y-idfs by 3.3% and ddfs by 2.2% compared to et alone in a broader risk population (~40% stg ii) tox: ribo+et g3-4 neutropenia (43.8%) relatively short fup (median 34m)! #bcsm 
Medical Oncologist | Medical research fellow at @Julesbordet Institute #bcsm